More than one in two cancer patients at a US cancer center experienced symptoms of long COVID-19 for more than six months after initial infection, according to a study published today in eLife.
Feb 7, 2023
0
4
People with weakened immune systems remain more likely to die if hospitalized with COVID-19 than patients with normal immune systems, a new UK study has confirmed.
Feb 1, 2023
0
5
For immunocompromised adults, adherence to U.S. Centers for Disease Control and Prevention mRNA monovalent COVID-19 booster dose recommendations is low, according to a study published online Jan. 20 in JAMA Network Open.
Jan 25, 2023
0
8
The last of six COVID monoclonal antibody treatments has lost its federal authorization because, like the others, it no longer works against the newest Omicron subvariants.
Dec 5, 2022
0
23
Patients with cancer and a weakened immune system who are treated with immunotherapies tend to fare far worse from COVID-19 than those who haven't received such therapies in the three months before their COVID diagnosis, ...
Nov 3, 2022
0
39
Georgios Sotiriou, principal researcher at the Department of Microbiology, Tumor and Cell Biology, and his colleagues have developed a durable coating for medical devices which is activated by light, providing on-demand disinfection.
Nov 2, 2022
0
5
A panel of investigational monoclonal antibodies (mAbs) targeting different sites of the Epstein-Barr virus (EBV) blocked infection when tested in human cells in a laboratory setting. Moreover, one of the experimental mAbs ...
Oct 27, 2022
0
34
An international team of researchers has developed a way to modify the CAR T engineering process to create cells that can assist in fighting fungal infections in the lungs. In their paper published in the journal Science ...
Do patients with prolonged infections contribute to the emergence of new SARS-CoV-2 variants? A research team from the Leibniz Institute of Virology (LIV) and the University Medical Center Hamburg-Eppendorf (UKE) has investigated ...
Aug 17, 2022
0
75
A fourth dose of mRNA COVID-19 vaccine seems safe for immunocompromised individuals aged 12 years or older, according to research published in the July 15 issue of the U.S. Centers for Disease Control and Prevention Morbidity ...
Jul 18, 2022
0
2
